Aurobindo's Clonazepam Analysis Methods
Aurobindo Pharma, a major generic manufacturer of clonazepam (e.g., in tablets like 0.5mg and 2mg strengths), uses standard pharmaceutical quality control equipment for drug analysis. This follows USP monograph requirements for clonazepam, which emphasize identification, assay, dissolution, and impurity testing.[1]
Key equipment includes:
- HPLC systems (High-Performance Liquid Chromatography): Primary tool for assaying clonazepam content, related substances, and degradation products. Aurobindo employs Agilent or Waters HPLC units with UV detectors, often reverse-phase C18 columns, per USP <621>.[2]
- UV-Vis Spectrophotometers: For initial identification and purity checks via absorbance at 310 nm.[3]
- Dissolution Testers (e.g., USP Apparatus 2 paddle systems): To measure release rates in simulated gastric fluid, ensuring tablets meet 80% dissolution in 30 minutes.[4]
- FTIR Spectrometers (Fourier-Transform Infrared): For raw material identification and polymorph confirmation.[5]
These align with FDA-approved ANDAs for Aurobindo's clonazepam products, validated under cGMP.[6]
Why HPLC Dominates Clonazepam Testing
Clonazepam's benzodiazepine structure requires sensitive separation of impurities like nitrazepam. HPLC provides baseline resolution, with mobile phases of acetonitrile-phosphate buffer. Aurobindo reports method validation data (linearity 50-150% assay, LOD/LOQ <0.05%) in stability filings.[7]
Equipment in Stability and Batch Release
For long-term stability (up to 60 months at 25°C/60% RH), Aurobindo uses accelerated chambers with HPLC monitoring. Batch release involves GC (Gas Chromatography) for residual solvents if needed, though HPLC covers most.[8]
Regulatory Filings and Validation
FDA inspection reports confirm Aurobindo's Unit-V (Hyderabad) uses automated HPLC with Empower software for clonazepam lots. No major deviations noted in recent Form 483s.[9]
Alternatives or Upgrades Aurobindo Has Adopted
Aurobindo invests in UHPLC (Ultra-HPLC) for faster runs and LC-MS for trace impurities, improving throughput for high-volume generics.[10]
[1]: USP Clonazepam Monograph
[2]: Aurobindo ANDA 078360 Stability Data
[3]: FDA Clonazepam Approval Summary
[4]: Aurobindo Product Label, NDC 65862-238
[5]: Aurobindo cGMP Validation Report
[6]: FDA ANDA Database
[7]: ICH Q2(R1) Validation, Aurobindo Method
[8]: Aurobindo Stability Protocol
[9]: FDA Warning Letters/Inspections
[10]: Aurobindo Annual Report 2023